Why is this Study Being Conducted?
Study participants will receive standard-of-care clinical examinations, work-ups, and imaging scans to follow their condition, in addition to biospecimen tests that are part of the study. The results of these tests will be compared with a study participant's final diagnosis. This information may be used in the future to predict the behavior of similar lung nodules in other patients
DECAMP Study 1 is being carried out to understand the ability of different types of biospecimen tests to predict if an indeterminate lung nodule seen on a study participant's screening CT scan is benign (noncancerous) or is eventually found to be malignant (cancerous).
|| A CT scan showing the indeterminate nodule (circled in blue) in the right lung.
Watch the DECAMP Video
The video features the study's principal investigator Avrum Spira, MD, MSc talking about the important role the DECAMP study plays in learning ways to detect who may be at greatest risk for developing lung cancer.
DECAMP Video Link